News & Updates
Filter by Specialty:
Nodal staging before SBRT does not affect survival in early-stage NSCLC
Patients with early-stage nonsmall cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) have similar overall survival (OS) regardless of nodal staging, reports a study. In addition, use of SBRT has shown a steady increase over the study period.
Nodal staging before SBRT does not affect survival in early-stage NSCLC
09 Nov 2023
COVID-19 ups risk of pulmonary fibrosis
Infection with COVID-19 may increase the risk of pulmonary fibrosis, and patients with a severe disease are at greater risk of developing this complication, suggests a recent study.
COVID-19 ups risk of pulmonary fibrosis
09 Nov 2023
Sexual dysfunction affects >50 percent of patients with schizophrenia
Sexual dysfunction is highly prevalent in schizophrenia, affecting >50 percent of patients. Treatment of comorbid depression may be an effective strategy to improve sexual health, according to a meta-analysis.
Sexual dysfunction affects >50 percent of patients with schizophrenia
09 Nov 2023
Brexpiprazole improves agitation in Alzheimer’s dementia
A double-blind, placebo-controlled, randomized clinical trial reports significant improvement in agitation with brexpiprazole vs placebo among patients with Alzheimer’s dementia.
Brexpiprazole improves agitation in Alzheimer’s dementia
09 Nov 2023
LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo
Use of the lung immune prognostic index (LIPI) score can help predict the efficacy of combination therapy of programmed cell death (PD)-1/PD-ligand 1 (PD-L1) blockade and chemotherapy (CT) in patients with advanced nonsmall cell lung cancer (NSCLC), suggests a study.